| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sari G Ferber, Reut Hazani, Gal Shoval, Aron Welle. Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives. Current neuropharmacology. vol 19. issue 3. 2021-11-03. PMID:32351183. |
this opens new windows of opportunity for treatment with cannabinoids such as cannabidiol (cbd) as no other pharmacological treatment has shown long-lasting improvement in the bpd population to date. |
2021-11-03 |
2023-08-13 |
Not clear |
| Christine Mary Hallinan, Jane Maree Gunn, Yvonne Ann Bonom. Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis. BMJ open. vol 11. issue 10. 2021-11-03. PMID:34686558. |
we sought to explore physician perspectives on the prescribing of cannabinoids to patients to gain a deeper understanding of the issues faced by prescriber and public health advisors in the rollout of medicinal cannabis. |
2021-11-03 |
2023-08-13 |
Not clear |
| Steven L Anderson, Brian Pearson, Roger Kjelgren, Zachary Bry. Response of essential oil hemp (Cannabis sativa L.) growth, biomass, and cannabinoid profiles to varying fertigation rates. PloS one. vol 16. issue 7. 2021-11-02. PMID:34324496. |
response of essential oil hemp (cannabis sativa l.) growth, biomass, and cannabinoid profiles to varying fertigation rates. |
2021-11-02 |
2023-08-13 |
Not clear |
| Steven L Anderson, Brian Pearson, Roger Kjelgren, Zachary Bry. Response of essential oil hemp (Cannabis sativa L.) growth, biomass, and cannabinoid profiles to varying fertigation rates. PloS one. vol 16. issue 7. 2021-11-02. PMID:34324496. |
five essential oil hemp (cannabis sativa l.) cultivars (cherry blossom, cherry blossom (tuan), berry blossom, cherry wine, and cherry blossom × trump) were treated with six fertigation treatments to quantify the effects of synthetic fertilizer rates and irrigation electrical conductivity on plant growth, biomass accumulation, and cannabinoid profiles. |
2021-11-02 |
2023-08-13 |
Not clear |
| Nirushi Kuhathasan, Luciano Minuzzi, James MacKillop, Benicio N Fre. The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study. Journal of medical Internet research. vol 23. issue 10. 2021-11-02. PMID:34704957. |
although insomnia is one of the main reasons individuals seek medicinal cannabis, little is known about the profile of cannabinoid use or the perceived benefit of the use of cannabinoids in daily life. |
2021-11-02 |
2023-08-13 |
Not clear |
| Erik B Oleson, Jibran Y Khokha. Cannabinoids: Emerging developments in neuropsychopharmacology and biological psychiatry. Progress in neuro-psychopharmacology & biological psychiatry. vol 110. 2021-11-01. PMID:33737216. |
cannabinoids from the cannabis plant were one of the earliest psychoactive phytochemicals harnessed by humanity for their medicinal properties and remain one of the most frequently used and misused classes of chemicals in the world. |
2021-11-01 |
2023-08-13 |
Not clear |
| Joshua D Brown, Kevin J Rivera Rivera, Leilanie Y Crespo Hernandez, Matthew R Doenges, India Auchey, Thanh Pham, Amie J Goodi. Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions. Journal of clinical pharmacology. vol 61 Suppl 2. 2021-11-01. PMID:34396558. |
in addition to a long history of recreational and nonmedical use, natural cannabinoids are increasingly used as prescription products, through medical cannabis programs, and as consumer health products. |
2021-11-01 |
2023-08-13 |
Not clear |
| Joshua D Brown, Kevin J Rivera Rivera, Leilanie Y Crespo Hernandez, Matthew R Doenges, India Auchey, Thanh Pham, Amie J Goodi. Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions. Journal of clinical pharmacology. vol 61 Suppl 2. 2021-11-01. PMID:34396558. |
despite anecdotal safety evidence, cannabis and cannabinoids are pharmacologically complex and pose risks for adverse drug events and drug-drug interactions. |
2021-11-01 |
2023-08-13 |
Not clear |
| Elisa Landucci, Costanza Mazzantini, Daniele Lana, Pier Luigi Davolio, Maria Grazia Giovannini, Domenico E Pellegrini-Giampietr. Neuroprotective Effects of Cannabidiol but Not Δ International journal of molecular sciences. vol 22. issue 18. 2021-11-01. PMID:34575932. |
neuroprotective effects of cannabidiol but not Δ (1) background: over the past 10 years, a number of scientific studies have demonstrated the therapeutic potential of cannabinoid compounds present in the |
2021-11-01 |
2023-08-13 |
Not clear |
| Robin Visvanathar, Maria Papanikolaou, Diana Aline Nôga, Marina Pádua-Reis, Adriano Bretanha Lopes Tort, Martina Blunde. Hippocampal Cb Reviews in the neurosciences. 2021-10-30. PMID:34717053. |
ongoing debates worldwide about the legislation of medical cannabis further motivates research into cannabinoid function within the central nervous system (cns). |
2021-10-30 |
2023-08-13 |
Not clear |
| Ute Mareck, Gregor Fusshöller, Hans Geyer, Marilyn A Huestis, Anja B Scheiff, Mario Thevi. Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use. Drug testing and analysis. vol 13. issue 3. 2021-10-28. PMID:33125823. |
according to the world anti-doping agency (wada) regulations, cannabinoids use is prohibited in competition except for cannabidiol (cbd) use. |
2021-10-28 |
2023-08-13 |
human |
| Ute Mareck, Gregor Fusshöller, Hans Geyer, Marilyn A Huestis, Anja B Scheiff, Mario Thevi. Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use. Drug testing and analysis. vol 13. issue 3. 2021-10-28. PMID:33125823. |
however, due to the fact that cbd isolated from cannabis plants may contain additional minor cannabinoids, the permissible use of cbd can lead to unintentional violations of antidoping regulations. |
2021-10-28 |
2023-08-13 |
human |
| Uma Anand, Barbara Pacchetti, Praveen Anand, Mikael Hans Sodergre. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. Pain management. vol 11. issue 4. 2021-10-28. PMID:33703917. |
unlike pure delta-9-tetrahydrocannabinol (thc), full-spectrum products contain naturally occurring cannabinoids and have been reported to show improved efficacy or tolerability, attributed to synergy between cannabinoids and other components in the cannabis plant. |
2021-10-28 |
2023-08-13 |
Not clear |
| Oliver Hulland, Jessica Oswal. Cannabinoids and Pain: The Highs and Lows. Rheumatic diseases clinics of North America. vol 47. issue 2. 2021-10-28. PMID:33781494. |
the medicolegal landscape of cannabis continues to change, and with ever increasing access there has been a concurrent proliferation of research seeking to understand the utility of cannabinoids in treating innumerable conditions with pain at the forefront. |
2021-10-28 |
2023-08-13 |
Not clear |
| Oliver Hulland, Jessica Oswal. Cannabinoids and Pain: The Highs and Lows. Rheumatic diseases clinics of North America. vol 47. issue 2. 2021-10-28. PMID:33781494. |
this article seeks to summarize clinically relevant findings in cannabinoid research to better prepare clinicians in the utility of cannabis in the treatment of pain. |
2021-10-28 |
2023-08-13 |
Not clear |
| Raul Felipe Palma-Álvarez, Albert Soriano-Dia, Elena Ros-Cucurull, Constanza Daigre, Pedro Serrano-Pérez, Germán Ortega-Hernández, Marta Perea-Ortueta, David Gurrea Salas, Josep-Antoni Ramos-Quiroga, Lara Grau-Lópe. Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review. Journal of dual diagnosis. vol 17. issue 2. 2021-10-28. PMID:33902405. |
catatonia related to cannabis and synthetic cannabinoids: a review. |
2021-10-28 |
2023-08-13 |
Not clear |
| Raul Felipe Palma-Álvarez, Albert Soriano-Dia, Elena Ros-Cucurull, Constanza Daigre, Pedro Serrano-Pérez, Germán Ortega-Hernández, Marta Perea-Ortueta, David Gurrea Salas, Josep-Antoni Ramos-Quiroga, Lara Grau-Lópe. Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review. Journal of dual diagnosis. vol 17. issue 2. 2021-10-28. PMID:33902405. |
cannabis and synthetic cannabinoids (sc) are related to several neuropsychiatric symptoms and disorders, especially psychotic symptoms and disorders. |
2021-10-28 |
2023-08-13 |
Not clear |
| Mahnaz Abdollahi, Fatemeh Sefidkon, Afshin Peirovi, Mohsen Calagari, Amir Mousav. Assessment of the Cannabinoid Content from Different Varieties of Cannabis sativa L. during the Growth Stages in Three Regions. Chemistry & biodiversity. 2021-10-28. PMID:34597470. |
assessment of the cannabinoid content from different varieties of cannabis sativa l. during the growth stages in three regions. |
2021-10-28 |
2023-08-13 |
Not clear |
| Jared S Wood, William H Gordon, Jeremy B Morgan, R Thomas Williamso. Calculated and experimental Magnetic resonance in chemistry : MRC. 2021-10-28. PMID:34617621. |
calculated and experimental cannabicitran is an important cannabinoid natural product produced by cannabis sativa and is often found at surprisingly high levels (up to ~10%) in "purified" commercial cannabidiol (cbd) extract preparations. |
2021-10-28 |
2023-08-13 |
Not clear |
| L Cinnamon Bidwell, Hollis C Karoly, Marco Ortiz Torres, Ashley Master, Angela D Bryan, Kent E Hutchiso. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology. 2021-10-28. PMID:34708254. |
a naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. |
2021-10-28 |
2023-08-13 |
Not clear |